Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / WUXIF - Week In Review: 3 $300 Million Deals For China Biopharma

WUXIF - Week In Review: 3 $300 Million Deals For China Biopharma

Wuxi AppTec Co. Ltd. - Class H
  • China Grand Pharma announced a $340 million agreement to develop and commercialize Telix Pharma's molecularly-targeted radiation products in China.
  • JW Therapeutics, a Shanghai cell therapy company, raised $300 million in its Hong Kong IPO at a market capitalization of $1 billion.
  • LianBio, a Shanghai-Princeton biotech, has been approved to start a Phase III trial of infigratinib in China.

For further details see:

Week In Review: 3 $300 Million Deals For China Biopharma
Stock Information
Company Name: Wuxi AppTec Co. Ltd. - Class H
Stock Symbol: WUXIF
Market: OTC
Menu
WUXIF WUXIF Quote WUXIF Short WUXIF News WUXIF Articles WUXIF Message Board
Get WUXIF Alerts

News, Short Squeeze, Breakout and More Instantly...